Life Technologies Corp: (NASD: LIFE)

$73.90

-0.04 (-0.05%)

Volume 277,172

May 24 09:49 AM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		73.88 - 73.95
	
		52wk Low - High
		39.73 - 74.33
	
		Previous Close
		73.94
	
		Avg. Volume
		3,025,599
	
		Industry
		MED PRODUCTS
	
		Market Cap
		12.64 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.98
	
		PE (Forward)
		17.56
	
		Current Year Est.
		4.22
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		184 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/22/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            17.56
                        
                            PEG Ratio
                            1.86
                        
                            Current Year Est.
                            4.22
                        
                            Current Quarter Estimate
                            0.96
                        
                            Most Accurate Estimate
                            0.96
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-06-2013
                        
                            EPS Last Year
                            4.06
                        
                            Expected Earnings Growth
                            9.42%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Life Technologies Corporation is a global biotechnology tools company. The company provides product and services that support researchers to accelerate scientific exploration, driving to discoveries and developments that make life better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of over 3,600 patents and exclusive licenses.Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.   
Full LIFE Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
LIFE Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.96	1.00	4.22	4.60
Number of Estimates	12	12	16	14
Low Estimate	0.94	0.94	4.10	4.28
High Estimate	0.97	1.08	4.37	NA
Year Ago EPS	0.96	0.92	3.98	4.22
EPS Growth	0.00%	8.79%	6.03%	9.06%

More LIFE Estimates

Average Earnings Estimates for LIFE

EPS Growth for LIFE

Industry Analysis

Name	Symbol	Previous Close
LIFE TECHNOLOGS	LIFE	73.94
CONCEPTUS INC	CPTS	30.98
ATRICURE INC	ATRC	9.30
INVIVO THERAPT	NVIV	2.94
TRANS1 INC	TSON	1.91
ABAXIS INC	ABAX	43.53
ADVAXIS INC	ADXS	0.04
BAXTER INTL	BAX	72.15
BIO-RAD LABS -A	BIO	115.57
BIOLIFE SOL INC	BLFS	0.34

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.

May 16, 2013

MedTech Industry Stock Update - May 2013

May, 15 2013 00:00

MedTech Industry Stock Update - May 2013

May, 15 2013 00:00

LIFE Beats Earnings, Margins Low

May 03, 2013

TMO's Earnings Beat, LIFE Buyout on Track

Apr 24, 2013

TMO Wins LIFE Takeover Battle

Apr 16, 2013

LIFE Takeover Battle Heats Up

Apr 11, 2013

Will Thermo Fisher Buy LIFE?

Apr 10, 2013

More LIFE Zacks Commentary

Financials

EPS TTM	4.06
Sales	3,799
Net Income	419
Price/Earnings	18.25
Price/Book	2.70
Price/Cash Flow	11.05
Price/Sales	3.31

More LIFE Financials

News

Personalized Medicine Market Analysis Report: 2013 Edition - M2

May 23, 2013

Biochip Products and Services Market - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 - M2

May 22, 2013

Life Technologies: 52-Week High Recently Eclipsed (LIFE) - Financial News Netwfork Online - 52-Week High-Lows

May 22, 2013

Downgrade Alert for Life Technologies (LIFE) - Comtex Smartrend(R)

May 21, 2013

Economic Model of the Life-time Cost Impact of Heart Valve Prosthetic Choice to be Presented at ISPOR Meeting - Businesswire

May 21, 2013

Life Technologies (LIFE) Showing Bullish Technicals But Could Fall Through $73.48 Support - Freshbrewedmedia

May 21, 2013

Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic Analyzers in Canada - Cnw Group

May 20, 2013

Life Technologies Earnings Review: 18 Days after Announcement Shares Down 0.1% (LIFE) - Comtex Smartrend(R)

May 20, 2013

See All News Stories on LIFE

Broker Recommendations

Current ABR	2.77
ABR (Last Week)	2.62
# of recs in ABR	13
Average Target Price	76.00
Industry Rank by ABR	184 out of 265
Rank in Industry	5 out of 73

More LIFE Broker Recommendations

Day Low - High	73.88 - 73.95
52wk Low - High	39.73 - 74.33
Previous Close	73.94
Avg. Volume	3,025,599
Industry	MED PRODUCTS
Market Cap	12.64 B
Div - Yield	0.00 - 0.00
Beta	0.98
PE (Forward)	17.56
Current Year Est.	4.22
Quarterly Earnings ESP	0.00%

PE (Forward)	17.56
PEG Ratio	1.86
Current Year Est.	4.22
Current Quarter Estimate	0.96
Most Accurate Estimate	0.96
Earnings ESP	0.00%
Next Earnings Report Date	08-06-2013
EPS Last Year	4.06
Expected Earnings Growth	9.42%

Username: Password:

Remember me [?]

Life Technologies Corp: (NASD: LIFE)

$73.90

-0.04 (-0.05%)

Volume 277,172

May 24 09:49 AM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED PRODUCTS

Zacks Commentary

Financials

News

Broker Recommendations